FORMULATION AND EVALUATION OF PRONIOSOMAL GEL FOR DOXYCYCLINE

Main Article Content

km saman Fatma
Mrs. priyanka Maurya
Dr .Jai Narayan Mishra

Keywords

Proniosomal gel, antifungal drug, topical drug delivery

Abstract

Proniosome gels' gives beneficial outcomes on degenerative joint sickness, there is a ton of interest in their utilization in transdermal drug conveyance frameworks. The reason for the ongoing review was to make and portray a proniosome of the NSAIDS drug, Doxycycline which might ship these prescriptions to the objective site all the more successfully and furthermore settle the issue with oral medicine organization. The viability of proniosome as another lipid for the effective dissemination of Doxycycline has been evaluated in the ongoing examination. By changing the convergence of phospholipids, cholesterol, Tween 60, and ethanol, and ph buffer7.4, proniosomes were upgraded. The plan of proniosome containing ethanol, cholesterol, and soy lecithin was moved along. Results: The best outcomes were gotten utilizing the F4 plan, which created round, unilamellar vesicles with a smooth surface when described. Proniosomes have been proposed as viable transporters for the skin organization of the medicine Doxycycline

Abstract 133 | pdf Downloads 103

References

1. Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontol. 2000;1996(10):45–78.
2. Eakle W, Ford C, Boyd R. Depth of penetration in periodontal pockets with oral irrigation. J Clin Periodontol. 1986;13:39–443. Pitcher G, Newman H, Strahan J. Access to subgingival plaque by disclosing agents using mouthrinses and direct irrigation. J Clin Periodontol. 1980;7:300–8.
3. Kornman KS. Controlled-release local delivery antimicrobials in periodontics: Prospects for the future. J Periodontol. 1993;64:782–91.
4. Rams TE, Slots J. Local delivery of antimicrobial agents in the periodontal pocket. Periodontol. 2000;1996(10):139–59.
5. Agrati C, Marianecci C, Sennato S, et al.. (2011). Multicompartment vectors as novel drug delivery systems: selective activation of Tγδ lymphocytes after zoledronic acid delivery. Nanomed Nanotechnol Biol Med 7:153–61
6. Ahmad MZ, Mohammed AA, Mokhtar Ibrahim M. (2017). Technology overview and drug delivery application of proniosome. Pharm Dev Technol 22:302–11.
7. Deepthi Annakula, Madhukar Rao Errabelli, Raju Jukanti, Suresh Bandari , Prabhakar reddy Veerareddy.Provesicular drug delivery systems: An overview and appraisal.Archives of Applied Science Research.2010;2(4): 135-146
8. Gupta A, Prajapati SK, Balamurugan M, Singh M, Bhatia D. Design and development of a proniosomal transdermal drug delivery system for captopril. Trop J Pharm Res. 2007;6:687–93.
9. Karim K, Mandal A, Biswas N, Guha A, Chatterjee S, Behera M, et al. Niosome: A future of targeted drug delivery systems. J Adv Pharm Technol Res. 2010;1(4):374–80.
10. Khan AR, Liu M, Khan MW, Zhai G. Progress in brain targeting drug delivery system by nasal route. J Control Release [Internet]. 2017;268(May):364–89. Available from: https://doi.org/ 10.1016/j.jconrel.2017.09.001
11. Alsarra IA, Hamed AY, Alanazi FK, Maghraby GM El. Chapter 8 Vesicular Systems for Intranasal Drug Delivery. (1)
12. Rajkumar J, Gv R, K TS, Burada S. RECENT UPDATE ON PRONIOSOMAL GEL AS TOPICAL DRUG DELIVERY RECENT UPDATE ON PRONIOSOMAL GEL AS TOPICAL DRUG DELIVERY SYSTEM. 2019;(January).
13. Malakar J, Datta PK, Dey S, Gangopadhyay A, Nayak AK. Proniosomes : a preferable carrier for drug delivery system. Elixir Int J Pharm. 2011;40(November):5120–4.
14. Pharmacology A, Vm S, Vv P, Ss P, Ob P. Review on Niosomes Review on Niosomes. 2019;(May 2018):0–7. 7. Yasam VR, Jakki SL, Natarajan J, Kuppusamy G. A review on novel
15. Arunothayanun P, Bernard MS, Craig DQ, Uchegbu IF, Florence AT. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm.